Candidemia in Cancer Patients: A Prospective, Multicenter Surveillance Study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC)
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
In a surveillance study of candidemia in cancer patients that was conducted by the European Organization for Research and Treatment of Cancer, 249 episodes were noted; Candida albicans was isolated in 70% (63) of the 90 cases involving patients with solid tumors (tumor patients) and in 36% (58) of the 159 involving those with hematologic disease (hematology patients). Neutropenia in tumor patients and acute leukemia and antifungal prophylaxis in hematology patients were significantly associated with non-albicans candidemia in a multivariate analysis. Overall 30-day mortality was 39% (97 of 249). In a univariate analysis, Candida glabrata was associated with the highest mortality rate (odds ratio, 2.66). Two multivariate analyses showed that mortality was associated with older age and severity of the underlying disease. Among hematology patients, additional factors associated with mortality were allogeneic bone marrow transplantation, septic shock, and lack of antifungal prophylaxis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Previous studies also showed a significant association between receipt of antifungal prophylaxis as well as acute leukemia and a higher incidence of candidemia caused by Candida species other than C. albicans (41).”
In the citing paper
“In cancer patients, Viscoli et al. [18] also suggested that C. glabrata was associated with a higher mortality rate.”
From Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: part I. Epidemiology and diagnosis (2009) · cites this paper as [18]
In the citing paper
“Other North American and European investigators confirmed these observations in larger hospital settings [10, 11, 13, 20, 22, 25, 26].”
From Epidemiology of Candidemia in Swiss Tertiary Care Hospitals: Secular Trends, 1991–2000 (2004) · cites this paper as [11]
In the citing paper
“Candidemia due to C. parapsilosis has increased in frequency in pediatric populations and appears to be associated with a lower mortality rate than is candidemia due to other species of Candida [110-113].”
From Guidelines for Treatment of Candidiasis (2004) · cites this paper as [113]
In the citing paper
“Candidemia due to C. glabrata may be associated with increased mortality in patients with cancer [113].”
From Guidelines for Treatment of Candidiasis (2004) · cites this paper as [113]
Citations
Cites
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
(2008) · The Concise Encyclopedia of Statistics · doi:10.1007/978-0-387-32833-1_5 · Cited by 2,670
Goodman, J. L., Winston, D. J., Greenfield, R. A., Chandrasekar, P. H., Fox, B., Kaizer, H., Shadduck, R. K., Shea, T. C., Stiff, P., Friedman, D. J., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199203263261301 · Cited by 1,174 · cited 1×
“However, this phenomenon has not been confirmed in large prospective studies [26-29].”
ResultSecular Trends in the Epidemiology of Nosocomial Fungal Infections in the United States, 1980-1990
Sague, C. M. B., Jarvis, W. R., & System, N. N. I. S. (1993) · Journal of Infectious Diseases · doi:10.1093/infdis/167.5.1247 · Cited by 1,140
Rex, J. H., Bennett, J. E., Sugar, A. M., Pappas, P. G., van der Horst, C. M., Edwards, J. E., Washburn, R. G., Scheld, W. M., Karchmer, A. W., Dine, A. P., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411173312001 · Cited by 1,039
Wingard, J. R., Merz, W. G., Rinaldi, M. G., Johnson, T. R., Karp, J. E., & Saral, R. (1991) · New England Journal of Medicine · doi:10.1056/nejm199110313251803 · Cited by 937 · cited 1×
“glabrata) in patients receiving fluconazole [23-25].”
Resistance of Candida species to fluconazole
Rex, J. H., Rinaldi, M. G., & Pfaller, M. A. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.1.1 · Cited by 877 · cited 1×
“glabrata) in patients receiving fluconazole [23-25].”
The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance
Hong Nguyen, M., Peacock, J. E., Morris, A. J., Tanner, D. C., Nguyen, M. L., Snydman, D. R., Wagener, M. M., Rinaldi, M. G., & Yu, V. L. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(95)00010-0 · Cited by 758 · cited 1×
“given about the patients' predisposing conditions [15].”
Survival Analysis: A Practical Approach.
Smith, P. J., Parmar, M. K. B., & David, M. (1996) · Journal of the American Statistical Association · doi:10.2307/2291609 · Cited by 730
Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality.
Fraser, V. J., Jones, M., Dunkel, J., Storfer, S., Medoff, G., & Dunagan, W. C. (1992) · Clinical Infectious Diseases · doi:10.1093/clind/15.3.414 · Cited by 679 · cited 2×
“glabrata [3, 4, 1522].”
Background
Cited by
Items 301–400 of 647
Emergence of resistant Candida in neutropenic patients
Nucci, M., & Colombo, A. L. (2002) · The Brazilian Journal of Infectious Diseases · doi:10.1590/s1413-86702002000300004 · Cited by 33
“institutions, antifungal prophylaxis was a strong predictor for non-albicans candidemia [35].”
BackgroundAlp, S., Arikan‐Akdagli, S., Gulmez, D., Ascioglu, S., Uzun, O., & Akova, M. (2015) · Mycoses · doi:10.1111/myc.12349 · Cited by 32
Impact of the transcriptional regulator, Ace2, on the Candida glabrata secretome
Stead, D. A., Walker, J., Holcombe, L., Gibbs, S. R. S., Yin, Z., Selway, L., Butler, G., Brown, A. J. P., & Haynes, K. (2010) · PROTEOMICS · doi:10.1002/pmic.200800706 · Cited by 29
Raman, N., Lee, M., Lynn, D. M., & Palecek, S. P. (2015) · Pharmaceuticals · doi:10.3390/ph8030483 · Cited by 32
Abbes, S., Sellami, H., Sellami, A., Makni, F., Mahfoudh, N., Makni, H., Khaled, S., & Ayadi, M. A. (2010) · Medical Mycology · doi:10.3109/13693786.2010.493561 · Cited by 32
Candida pseudorugosa sp. nov., a Novel Yeast Species from Sputum
Li, J., Xu, Y., & Bai, F. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.01391-06 · Cited by 32
“albicans have accounted for nearly 50% of all systemic Candida infections in many cancer centers since the late 1980s (2, 19, 34, 39, 42).”
BackgroundTseng, T.-Y., Chen, T., Ho, C., Lin, P., Chou, C.-H., Tsai, C.-T., Wang, J.-H., Chi, C.-Y., & Ho, M. (2017) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2016.08.015 · Cited by 32
“%) in patients with CG-BSI.”
BackgroundInfluentialInfections caused by non- Candida , non- Cryptococcus yeasts
Pfaller, M. A., Diekema, D. J., & Merz, W. G. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-5680-5.00010-4 · Cited by 32
Emerging Issues in Antibiotic Resistance in Blood-borne Infections
Karam, G. H., & Heffner, J. E. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.5.pc10-00 · Cited by 31
A Single‐Centre 10‐Year Experience with Candida Bloodstream Infections
Labbé, A., Pépin, J., Patiño, C., Castonguay, S., Restieri, C., & Laverdière, M. (2008) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2009/731070 · Cited by 31
“0–128 – – 75 0 25 Candida species‡ (4) Voriconazole <0.”
BackgroundInfluentialFungaemia in haematological malignancies: SEIFEM‐2015 survey
Criscuolo, M., Marchesi, F., Candoni, A., Cattaneo, C. M., Nosari, A., Veggia, B., Verga, L., Fracchiolla, N., Vianelli, N., Principe, M. I. D., et al. (2019) · European Journal of Clinical Investigation · doi:10.1111/eci.13083 · Cited by 31
“Recovery of neutropenia 2 (13) 47 (35) 5 (22)”
Bennett, F., Saksena, A. K., Lovey, R. G., Liu, Y., Patel, N. M., Pinto, P. A., Pike, R. E., Jao, E., GIRIJAVALLABHAN, V. M., Ganguly, A. K., et al. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.09.031 · Cited by 31
Ellis, M. E., Richardson, M. D., & de Pauw, B. (2000) · Hospital Medicine · doi:10.12968/hosp.2000.61.9.1415 · Cited by 31
Toubai, T., Tanaka, J., Ota, S., Shigematsu, A., Shono, Y., Ibata, M., Hashino, S., Kondo, T., Kakinoki, Y., Masauzi, N., et al. (2007) · Internal Medicine · doi:10.2169/internalmedicine.46.6021 · Cited by 31
“0% in patients who have had undergone a stem-cell transplantation (2).”
BackgroundRapid and simple differentiation of C. dubliniensis from C. albicans
Graf, B., Trost, A., Eucker, J., Göbel, U. B., & Adam, T. (2004) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2003.09.016 · Cited by 31
“In recent years, however, increasing incidence of non-albicans Candida species has been noticed (Viscoli et al., 1999).”
BackgroundSim, J. P. Y., Kho, B. C. S., Liu, H. S. Y., Yung, R. W. H., & Chan, J. C. W. (2005) · PubMed · Cited by 31
Caspofungin in Combination with Amphotericin B against Candida glabrata
Barchiesi, F., Spreghini, E., Fothergill, A. W., Arzeni, D., Greganti, G., Giannini, D., Rinaldi, M. G., & Scalise, G. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.6.2546-2549.2005 · Cited by 28
“glabrata are characterized by a high mortality rate, and they are difficult to treat due to a reduced susceptibility of this species to azole drugs, especially to fluconazole (2, 3, 9).”
BackgroundApplications of yeast in drug discovery
Ma, D. (2001) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8308-5_3 · Cited by 30
Two Cases of Fungemia due to Candida lusitaniae and a Literature Review
Viudes, A., Pemán, J., Cantón, E., Salavert, M., Ubeda, P., López-Ribot, J., & Gobernado, M. (2002) · European Journal of Clinical Microbiology and Infectious Diseases · doi:10.1007/s10096-002-0713-5 · Cited by 29
Evaluation of Vitek 2 for identification of yeasts in the clinical laboratory
Meurman, O., Koskensalo, A., & Rantakokko‐Jalava, K. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01409.x · Cited by 29
Ng, K. K., Schorr, C., Reboli, A. C., Zanotti, S. L., & Tsigrelis, C. (2015) · Scandinavian Journal of Infectious Diseases · doi:10.3109/23744235.2015.1028100 · Cited by 29
“Nevertheless, the attributable mortality is likely lower than all-cause mortality, as has been reported in hospitalized populations with candidemia not restricted to the ICU setting [8], and this warrants further study.”
BackgroundInterferon-gamma Immunotherapy in a Patient With Refractory Disseminated Candidiasis
Buddingh, E. P., Leentjens, J., van der Lugt, J., Dik, W. A., Gresnigt, M. S., Netea, M. G., Pickkers, P., & Driessen, G. J. A. (2015) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000000909 · Cited by 29
“are the most frequent fungal opportunistic pathogen in such patients,(4) with 30-day mortality rates reaching 40% in adult patients.(5,6) In the pediatric population, prognosis of invasive Candida infections is slightly better, but particularly in cases with poor response to antifungal therapy, mortality remains unacc…”
BackgroundDoxorubicin induces drug efflux pumps inCandida albicans
Kofla, G., Turner, V., Schulz, B., Storch, U., Froelich, D., Rognon, B., Coste, A. T., Sanglard, D., & Ruhnke, M. (2010) · Medical Mycology · doi:10.3109/13693786.2010.512022 · Cited by 28
Pasqualotto, A. C., & Severo, L. C. (2007) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01843.x · Cited by 28
Geotrichum capitatum septicemia in patients with acute myeloid leukemia. Report of three cases
Saghrouni, F., Abdeljelil, J. B., Youssef, Y. B., Abdeljelil, N. B., Gheith, S., Fathallah, A., & Saïd, M. B. (2012) · Medical Mycology Case Reports · doi:10.1016/j.mmcr.2012.09.003 · Cited by 28
Antifungal resistance: the clinical front.
Perfect, J. R. (2004) · PubMed · Cited by 28
Kim, S. H., Shin, J. H., Kim, E. C., Lee, K., Kim, M., Lee, W. G., Uh, Y., Lee, H. S., Lee, M., Jeong, S. H., et al. (2008) · Medical Mycology · doi:10.1080/13693780802291445 · Cited by 28
Empirical antifungal therapy in selected patients with persistent febrile neutropenia
Aguilar‐Guisado, M., Espigado, I., Cordero, E., Noguer, M., Parody, R., Pachón, J., & Cisneros, J. M. (2009) · Bone Marrow Transplantation · doi:10.1038/bmt.2009.125 · Cited by 27
Kiraz, N., & Öz, Y. (2010) · Medical Mycology · doi:10.3109/13693786.2010.503195 · Cited by 27
Jeong, S. H., Kim, D. Y., Jang, J. H., Mun, Y., Choi, C. W., Kim, S., Kim, J. S., & Park, J. S. (2015) · Annals of Hematology · doi:10.1007/s00277-015-2545-2 · Cited by 27
Pagano, L., Dragonetti, G., Cattaneo, C. M., Marchesi, F., Veggia, B., Busca, A., Candoni, A., Prezioso, L., Criscuolo, M., Cesaro, S., et al. (2017) · Haematologica · doi:10.3324/haematol.2017.172536 · Cited by 27
“For many years, candidemia has been one of the most relevant IFI in patients with hematologic malignancies, with a high mortality rate.(6-8) Recent reports have shown that the incidence of candidemia is lower than in past years, probably because of the use of more effective prophylactic and/or therapeutic antifungal a…”
BackgroundEleven-year retrospective survey of candidaemia in a university hospital in southwestern Greece
Spiliopoulou, A., Vamvakopoulou, S., Bartzavali, C., Dimitracopoulos, G. O., Anastassiou, E. D., & Christofidou, M. (2010) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03193.x · Cited by 27
“isolated from patients with clinical signs of infection, according to the European Organization for Research and Treatment of Cancer [4].”
MethodYamada, E., Nishikawa, H., Nomura, N., & Mitsuyama, J. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00355-10 · Cited by 26
“However, the increased prevalence of Candida glabrata isolates that exhibit reduced susceptibility to triazole antifungals and Candida krusei isolates that have developed intrinsic resistance to fluconazole and itraconazole has heightened concerns regarding the empirical use of triazolebased drugs, especially in the c…”
BackgroundVargas-Espíndola, L. A., Cuervo, S. I., Enciso-Olivera, J. L., Gómez-Rincón, J. C., Cetina, L. P. J., Sánchez, R., García-Guzmán, K., López-Mora, M. J., Álvarez, C., Cortés, J. A., et al. (2023) · Journal of Fungi · doi:10.3390/jof9040400 · Cited by 26
“Interestingly, advanced age, the presence of organ dysfunction, kidney failure, and neutropenia were not related to mortality, as previously described in different studies [2,10,14,58,59].”
ResultTrend Reversal in the Frequency of Mycoses in Hematological Neoplasias
Donhuijsen, K., Petersen, P., & Schmid, K. W. (2008) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2008.0501 · Cited by 26
Pappas, P. G., Kauffman, C. A., Andes, D. R., Benjamin, D. K., Calandra, T., Edwards, J. E., Filler, S. G., Fisher, J. F., Kullberg, B. J., Ostrosky-Zeichner, L. L., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/598961 · Cited by 26
“Los factores de riesgo implicados con más frecuencia incluyen el uso de agentes antibacteriales de amplio espectro, el uso de catéteres venosos centrales, la recepción de alimentación parenteral, la recepción de terapia de sustitución renal por parte de pacientes en UCI, neutropenia, el uso de dispositivos ortopédicos…”
BackgroundChryssanthou, E., Cherif, H., Petrini, B., Kalin, M., & Björkholm, M. (2004) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540410021108 · Cited by 26
Candidainfections in the intensive care unit: epidemiology, risk factors and therapeutic strategies
Bassetti, M., Righi, E., Tumbarello, M., Biagio, A. D., Rosso, R., & Viscoli, C. (2006) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.4.5.875 · Cited by 26
Self-citationLong-term antifungal prophylaxis in high-risk hematopoietic stem cell transplant recipients
Bow, E. J. (2005) · Medical Mycology · doi:10.1080/13693780400019990 · Cited by 26
Will resistance in fungi emerge on a scale similar to that seen in bacteria?
Hof, H. (2008) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-007-0451-9 · Cited by 25
Invasive candidiasis in the ICU: evidence based and on the edge of evidence
Hollenbach, E. (2008) · Mycoses · doi:10.1111/j.1439-0507.2008.01571.x · Cited by 25
Candidemia in the cancer patient: diagnosis, treatment, and future directions
McCarthy, M. W., & Walsh, T. J. (2018) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2018.1536546 · Cited by 24
Peterson, L. S., Ostermann, J. K., Rieger, H., Ostermann, H., & Rieger, C. T. (2013) · Mycoses · doi:10.1111/myc.12086 · Cited by 24
Ridola, V., Chachaty, É., Raimondo, G., Corradini, N., Brugières, L., Valteau‐Couanet, D., & Hartmann, O. (2003) · Pediatric Blood & Cancer · doi:10.1002/pbc.10452 · Cited by 24
“Furthermore, candidemia developed early after the diagnosis of the malignancy [20].”
Increasing Fungal Infections in the Intensive Care Unit
Pauw, B. E. D. (2006) · Surgical Infections · doi:10.1089/sur.2006.7.s-93 · Cited by 24
Kebabci, N., van Diepeningen, A. D., Ener, B., Ersal, T., Meijer, M., Al‐Hatmi, A. M. S., Özkocaman, V., Ursavaş, A., Çetinoğlu, E. D., & Akalın, H. (2013) · Mycoses · doi:10.1111/myc.12142 · Cited by 23
Caspofungin in the treatment of candidosis and aspergillosis
Maertens, J. A., & Boogaerts, M. (2003) · International Journal of Infectious Diseases · doi:10.1016/s1201-9712(03)90003-8 · Cited by 23
Hof, H. (2008) · Mycoses · doi:10.1111/j.1439-0507.2008.01522.x · Cited by 22
Treatment of Invasive Candidiasis in Immunocompromised Pediatric Patients
Fisher, B. T., & Zaoutis, T. E. (2008) · Pediatric Drugs · doi:10.2165/00148581-200810050-00003 · Cited by 22
Madney, Y., Shalaby, L., ElAnany, M. G., Adel, N., Nasr, E. M. E. M., Alsheshtawi, K., Younes, A., & Hafez, H. (2019) · Mycoses · doi:10.1111/myc.13002 · Cited by 22
Infections in the Cancer Patient
Marchetti, O., Tissot, F., & Calandra, T. (2016) · Elsevier eBooks · doi:10.1016/b978-0-7020-6285-8.00079-4 · Cited by 22
Stead, D., Findon, H., Yin, Z., Walker, J., Selway, L., Cash, P., Dujon, B. A., Hennequin, C., Brown, A. J. P., & Haynes, K. (2005) · PROTEOMICS · doi:10.1002/pmic.200401064 · Cited by 22
Gottfreðsson, M., Vredenburgh, J. J., Xu, J., Schell, W. A., & Perfect, J. R. (2003) · Cancer · doi:10.1002/cncr.11470 · Cited by 22
New pathogens in neutropenic patients with cancer: an update for the new millennium
Zinner, S. H. (2000) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(00)00237-5 · Cited by 22
Lee, I., Morales, K. H., Zaoutis, T. E., Fishman, N. O., Nachamkin, I., & Lautenbach, E. (2010) · American Journal of Infection Control · doi:10.1016/j.ajic.2010.02.016 · Cited by 18
Zhang, Y., Li, W., Mi, C., Chen, H., Yu, H., Fang, C., Sun, N., Wang, Q., Luo, T., Luo, K., et al. (2015) · Mycopathologia · doi:10.1007/s11046-015-9979-x · Cited by 21
Emerging and Re-emerging Pathogens and Diseases, and Health Consequences of a Changing Climate
Polgreen, P. M., & Polgreen, E. L. (2016) · Elsevier eBooks · doi:10.1016/b978-0-7020-6285-8.00004-6 · Cited by 21
Yoo, J., Kim, S., Hur, S., Ha, J., Huh, K., & Cha, W. C. (2021) · JMIR Medical Informatics · doi:10.2196/24651 · Cited by 21
“Model Development Stage 1: Feature Selection and Preprocessing Upon review of clinical-domain literature on candidemia risk factors, we identified 210 variables [2,13,14,25-27] that have been widely used in the development of machine learning algorithms in other clinical fields.”
BackgroundCornely, O. A., Vázquez, J. A., Waele, J. J. D., Betts, R. F., Rotstein, C., Nucci, M., Pappas, P. G., & Ullmann, A. J. (2013) · Mycoses · doi:10.1111/myc.12104 · Cited by 21
BOSSCHE, H. V. (2002) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.12.2.151 · Cited by 21
“Itraconazole is also indicated for maintenance therapy of cryptococcosis in AIDS [14].”
BackgroundInfluentialMiyazaki, T., & Kohno, S. (2015) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2015.1058157 · Cited by 20
Ding, L., Li, T., Bai, C., Zhang, Q., Li, Z., & Li, X. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-05780-x · Cited by 20
“glabrata complex was associated with the highest mortality rate compared with other Candida species [39], and Tedeschi S et al.”
ResultEpidemiology of candidemia at King Chulalongkorn Memorial Hospital, Thailand
Tritipwanit, K., Chindamporn, A., & Suankratay, C. (2005) · Cited by 20
Kadosh, D., Najvar, L. K., Bocanegra, R. A., Olivo, M., Kirkpatrick, W. R., Wiederhold, N. P., & Patterson, T. F. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01144-16 · Cited by 20
Grisin, T., Bories, C., Loiseau, P. M., & Bouchemal, K. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.01.048 · Cited by 20
Mohamed, N. A., Pathmanathan, S. G., Hussin, H., & Zaini, A. B. (2018) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.9634 · Cited by 20
“glabrata were more prevalent among the former [22].”
BackgroundCandida famataFungemia in a Cancer Patient: Case Report
Krcmery, V., & Kunova, A. (2000) · Journal of Chemotherapy · doi:10.1179/joc.2000.12.2.189 · Cited by 20
Self-citationJarque, I., Saavedra, S., Martin, G., Pemán, J., Pérez-Bellés, C., & Sanz, M. Á. (2000) · PubMed · Cited by 20
da Silva, A. M. P. D. S., de Moraes‐Pinto, M. I., Pignati, L. T., Teixeira, B. B., Lima, A. P. C., Germano, P. C. P., Petrilli, A. S., Marques, L. M. A., & Carlesse, F. A. D. M. C. (2020) · Mycoses · doi:10.1111/myc.13106 · Cited by 19
Opportunistic and Systemic Fungi
Kosmidis, C., & Denning, D. W. (2016) · Elsevier eBooks · doi:10.1016/b978-0-7020-6285-8.00189-1 · Cited by 19
Erdem, İ., Oğuzoğlu, N., Öztürk-Engin, D., Özgültekin, A., Inan, A. S., Ceran, N., Kaya, F., Genç, İ., & Göktaş, P. (2010) · Medical Principles and Practice · doi:10.1159/000320305 · Cited by 19
Adıgüzel, N., Karakurt, Z., Güngör, G., Moçin, Ö. Y., Acartürk, E., Soğukpınar, Ö., & Baran, R. (2010) · PubMed · Cited by 19
Leveduras nos tratos urinário e respiratório: infecção fúngica ou não?
Vidigal, P. G., & Svidzinski, T. I. E. (2009) · Jornal Brasileiro de Patologia e Medicina Laboratorial · doi:10.1590/s1676-24442009000100009 · Cited by 19
“Consequentemente, este fato eleva as complicações para a escolha do tratamento a ser adotado inicialmente(40, 64, 74, 88, 91, 97).”
BackgroundInvasive fungal infections in cancer patients
Anaissie, E. J., Grazziutti, M., & Nucci, M. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-5680-5.00020-7 · Cited by 19
Antifungal prophylaxis and pre-emptive therapy
Viscoli, C. (2009) · Drugs · doi:10.2165/11315540-000000000-00000 · Cited by 18
“yeasts, Candida albicans was the most frequently isolated species of Candida isolates for years, until a surveillance study of fungaemia in cancer patients showed that non-albicans Candida had become prevalent among patients with leukemia and lymphoma.([11]) This phenomenon seems to be common to almost all compromised…”
BackgroundSelf-citationInvasive Candida infections in the ICU
Eggimann, P., Barberini, L., Calandra, T., & Marchetti, O. (2012) · Mycoses · doi:10.1111/j.1439-0507.2011.02151.x · Cited by 18
Recomendaciones para el manejo de la candidemia en neonatos en América Latina
Santolaya, M. E., Matute, T. A., Telles, F. D. Q., Colombo, A. L., Zurita, J., Tiraboschi, I. N., Cortés, J. A., Thompson-Moya, L., Guzmán-Blanco, M., Sifuentes‐Osornio, J., et al. (2013) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2013.06.002 · Cited by 18
Kharadi, G. J., & Patel, K. D. (2010) · Applied Organometallic Chemistry · doi:10.1002/aoc.1617 · Cited by 18
Design, Synthesis, Antifungal Activity and Molecular Docking of Thiochroman-4-one Derivatives
Zhong, Y., Han, X., Li, S., Qi, H., Song, Y., & Qiao, X. (2017) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.c17-00274 · Cited by 18
Management of infections caused by Candida glabrata
Sobel, J. D. (2000) · Current Infectious Disease Reports · doi:10.1007/s11908-000-0069-x · Cited by 18
Invasive Aspergillosis in Children With Acute Leukemia at a Resource-limited Oncology Center
Jain, S., & Kapoor, G. (2014) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0000000000000159 · Cited by 18
“Median hospital stay 17 (2-44) Death due to aspergillosis (attributable) 05 (14.”
BackgroundPneumonia due to Candida krusei
Petrocheilou, V., Georgilis, K., Kontoyannis, D. A., Nanas, J., Prifti, H., Costopoulos, H., & Stamatelopoulos, S. F. (2002) · Clinical Microbiology and Infection · doi:10.1046/j.1469-0691.2002.00488.x · Cited by 18
Seghir, A., Boucherit‐Otmani, Z., Sari-Belkharroubi, L., & Boucherit, K. (2014) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2014.08.005 · Cited by 17
Malý, J., Szárszoi, O., Netuka, I., Dorazilová, Z., & Pirk, J. (2013) · Journal of Cardiac Surgery · doi:10.1111/jocs.12258 · Cited by 17
Liu, D., Luo, P., Sun, W., Zhang, L., & Wang, Z. (2010) · Analytical Biochemistry · doi:10.1016/j.ab.2010.04.023 · Cited by 17
Çalgın, M. K., & Çetinkol, Y. (2018) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.9698 · Cited by 17
“albicans still causes about 60% of cases [5,6].”
BackgroundVicari, P., Pinheiro, R. F., Chauffaille, M. D. L., Yamamoto, M., & Figueiredo, M. S. (2003) · The Brazilian Journal of Infectious Diseases · doi:10.1590/s1413-86702003000600012 · Cited by 17
“Dissemination to the joint is most frequently provoked by intra-articular inoculation, including injection, surgery and prosthesis; or by hematogenous dissemination, usually in intravenous drug abusers [4,5].”
BackgroundInfluentialGirmenia, C., Finolezzi, E., Federico, V., Santopietro, M., & Perrone, S. (2011) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2011.013 · Cited by 17
Self-citationTratamiento antifúngico empírico en pacientes seleccionados con fiebre persistente y neutropenia
Cisneros, J. M., Espigado, I., Rivero, A., de León, F. L., Parra, J., Collado, A., Lomas, J. M., & Pachón, J. (2005) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/s0213-005x(05)75041-2 · Cited by 17
“%) y en un 10% de los casos como shock séptico 17 . recomendadas en el cuidado de los pacientes con sepsis grave o shock séptico 30 .”
Factors Influencing Non-albicans Candidemia: A Case–Case–Control Study
Kofteridis, D. P., Valachis, A., Dimopoulou, D., Andrianaki, A. M., Christidou, A., Maraki, S., Spernovasilis, N. A., & Samonis, G. (2017) · Mycopathologia · doi:10.1007/s11046-017-0146-4 · Cited by 17
Optimal use of existing and new antifungal drugs
Rogers, T. R. (2001) · Current Opinion in Critical Care · doi:10.1097/00075198-200108000-00005 · Cited by 17
Mariné, M., Serena, C., Fernández-Torres, B., Pastor, F. J., & Guarro, J. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.11.4757-4759.2005 · Cited by 17
“albicans (3), and it causes a high mortality rate (12).”
BackgroundBordon, F., Jullian, N., Ferrari, P., Girard, A.-M., Bocquel, M. T., Biton, J., Bouquin, N., & Haesslein, J. (2003) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2003.11.025 · Cited by 16
Apport du milieu chromogène CHROMagar® Candida dans le diagnostic mycologique des levures
Ouanes, A., Kouais, A., Marouen, S., Sahnoun, M., Jemli, B., & Gargouri, S. (2013) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2013.07.058 · Cited by 16
Usefulness of determination of β-D-glucan in the diagnosis of deep mycosis – experience in Japan
Yoshida, M. W. (2006) · Medical Mycology · doi:10.1080/13693780600897997 · Cited by 16
Busca, A., Tortorano, A. M., & Pagano, L. (2015) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2015.09.002 · Cited by 15
“Candida glabrata, Candida krusei, Candida norvegensis and Candida inconspicua, are frequently isolated [18–21].”
BackgroundEpidemiology of Systemic Fungal Diseases: An Overview
Park, B. J., Chiller, T. M., Brandt, M. E., & Warnock, D. W. (2010) · Springer eBooks · doi:10.1007/978-1-4419-6640-7_2 · Cited by 15
Blood culture in neutropenic patients with Fever.
Meidani, M., Rostami, M., & Moulaee, S. (2012) · PubMed Central · Cited by 15
Candida : What Should Clinicians and Scientists Be Talking About?
Spellberg, B. J., Marr, K. A., & Filler, S. G. (2014) · ASM Press eBooks · doi:10.1128/9781555817176.ch1 · Cited by 15
Systemic Candidiasis: Candidemia and Deep-Organ Infections
Clancy, C. J., & Nguyen, M. H. (2014) · ASM Press eBooks · doi:10.1128/9781555817176.ch27 · Cited by 15
Metadata
- Authors
- Viscoli, C., Girmenia, C., Marinus, A., Collette, L., Martino, P., Vandercam, B., Doyen, C., Lebeau, B., Spence, D., Krcmery, V., De Pauw, B., Meunier, F., & the Invasive Fungal Infection Group of the EORTC
- Affiliations
- University of Genoa (IT)
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 1999-05
- Volume
- 28
- Issue
- 5
- Pages
- 1071-1079
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2126536749
- Cited by
- 601
- References
- 29
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 5 · 2023: 11 · 2022: 6 · 2021: 9 · 2020: 9 · 2019: 8 · 2018: 16 · 2017: 15 · 2016: 16 · 2015: 22 · 2014: 27 · 2013: 31 · 2012: 25
- FWCI
- 21.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)) (submittedVersion)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Oncology › Neutropenia and Cancer Infections
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Keywords
- candidemia, invasive fungal infections, cancer patients, Candida albicans, non-albicans Candida, Candida glabrata, solid tumors, hematologic malignancies, acute leukemia, neutropenia, antifungal prophylaxis, allogeneic bone marrow transplantation, septic shock, 30-day mortality, risk factors
- MeSH terms
- Adult, Aged, Aged, 80 and over, Candida albicans, Candidiasis, Child, Child, Preschool, Cross Infection, Female, Humans, Male, Middle Aged, Neoplasms, Neutropenia, Population Surveillance, Prospective Studies, Multivariate Analysis, Survival Analysis, Hematologic Neoplasms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.